炎症性肠病患者假性息肉与结直肠肿瘤无关联
这项多中心回顾性队列研究纳入1582例炎症性肠病患者,其中462例(29.2%)有假性息肉。中位随访4.8年,假性息肉与晚期结直肠肿瘤风险无独立关联(校正风险比1.17;95%CI 0.59-2.31),但假性息肉患者结肠切除术率显著更高(P=0.01)。作者认为不应仅因假性息肉存在而缩短监测间隔。
要点
- 假性息肉与更严重炎症、更广病变范围相关,与原发性硬化性胆管炎可能性更低相关。
- 假性息肉未独立增加晚期结直肠肿瘤风险(校正风险比1.17;95%CI 0.59-2.31)。
- 假性息肉患者结肠切除术率显著更高(P=0.01)。
核心结论
- 在炎症性肠病患者中,假性息肉与更严重的结肠炎症和更广的病变范围相关,并与更高的结肠切除术率相关,但与任何程度的结直肠肿瘤发生均无关联。
- 作者认为监测间隔不应仅基于假性息肉的存在而缩短。
研究设计与样本
- 多中心回顾性队列研究,纳入1997年1月至2017年1月在美国纽约或荷兰的5家学术医院和2家大型非学术医院接受结直肠肿瘤结肠镜监测的炎症性肠病患者。
- eligible患者为确诊结肠病变且病程至少8年(若合并原发性硬化性胆管炎则病程不限),无晚期结直肠肿瘤(高级别异型增生或结直肠癌)或结肠切除术史;共1582例符合条件,其中462例(29.2%)有假性息肉。
主要发现
- 假性息肉与更严重炎症相关(校正比值比1.32;95%CI 1.13-1.55),与更广病变范围相关(校正比值比1.92;95%CI 1.34-2.74),与原发性硬化性胆管炎可能性更低相关(校正比值比0.38;95%CI 0.26-0.55)。
- 中位随访4.8年期间,有无假性息肉的患者发生晚期结直肠肿瘤的时间无显著差异。
- 假性息肉未独立增加晚期结直肠肿瘤风险(校正风险比1.17;95%CI 0.59-2.31)。
- 假性息肉患者的结肠切除术率显著更高(P=0.01)。
临床怎么用
- 作者认为,监测间隔不应仅基于假性息肉的存在而缩短。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Patients with inflammatory bowel diseases who have postinflammatory polyps (PIPs) have an increased risk of colorectal neoplasia (CRN). European guidelines propose that patients with PIPs receive more frequent surveillance colonoscopies, despite limited evidence of this increased risk. We aimed to define the risk of CRN and colectomy in patients with inflammatory bowel diseases and PIPs. METHODS: We conducted a multicenter retrospective cohort study of patients with inflammatory bowel diseases who underwent colonoscopic surveillance for CRN, from January 1997 through January 2017, at 5 academic hospitals and 2 large nonacademic hospitals in New York or the Netherlands. Eligible patients had confirmed colonic disease with duration of at least 8 years (or any duration, if they also had primary sclerosing cholangitis) and no history of advanced CRN (high-grade dysplasia or colorectal cancer) or colectomy. The primary outcome was occurrence of advanced CRN according to PIP status; secondary outcomes were occurrence of CRN (inclusive of low-grade dysplasia) and colectomy. RESULTS: Of 1582 eligible patients, 462 (29.2%) had PIPs. PIPs were associated with more severe inflammation (adjusted odds ratio 1.32; 95% confidence interval [CI] 1.13-1.55), greater disease extent (adjusted odds ratio 1.92; 95% CI 1.34-2.74), and lower likelihood of primary sclerosing cholangitis (adjusted odds ratio 0.38; 95% CI 0.26-0.55). During a median follow-up period of 4.8 years, the time until development of advanced CRN did not differ significantly between patients with and those without PIPs. PIPs did not independently increase the risk of advanced CRN (adjusted hazard ratio 1.17; 95% CI 0.59-2.31). The colectomy rate was significantly higher in patients with PIPs (P = .01). CONCLUSIONS: In a retrospective analysis of data from 2 large independent surveillance cohorts, PIPs were associated with greater severity and extent of colon inflammation and higher rates of colectomy, but were not associated with development of any degree of CRN. Therefore, intervals for surveillance should not be shortened based solely on the presence of PIPs.
引用
- Mahmoud R, Shah SC, Ten Hove JR, et al. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases. Gastroenterology. 2018. PMID: 30529584. doi:10.1053/j.gastro.2018.11.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。